ArticleJournal of Korean medical science2020

Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies.

Ga Young Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.